Central VA Bank

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
VectorVest Logo
Central VA Bank (CVBK)
$0.84
(0.00%)
Wednesday, February 13, 2013
CVBK is undervalued compared to its Price of $0.84 per share , has below average safety , and is currently rated a Hold.

Central VA Bank (CVBK)


Bank (Southeast)


Company Information

Business: Central Virginia Bankshares, Inc., incorporated on March 7, 1986, is the bank holding for Central Virginia Bank (the Bank). The principal business of the Bank is to attract deposits and to loan or invest those deposits.

Capital Appreciation

Value: Value is a measure of a stock 's current worth. CVBK has a current Value of $0.98 per share. Therefore, it is undervalued compared to its Price of $0.84 per share. Value is computed from forecasted earnings per share, forecasted earnings growth, profitability, interest, and inflation rates. Value increases when earnings, earnings growth rate and profitability increase, and when interest and inflation rates decrease. VectorVest advocates the purchase of undervalued stocks. At some point in time, a stock 's Price and Value always will converge.

RV (Relative Value): RV is an indicator of long-term price appreciation potential. CVBK has an RV of 1.05, which is fair on a scale of 0.00 to 2.00. This indicator is far superior to a simple comparison of Price and Value because it is computed from an analysis of projected price appreciation three years out, AAA Corporate Bond Rates, and risk. RV solves the riddle of whether it is preferable to buy High growth, High P/E stocks, or Low growth, Low P/E stocks. VectorVest favors the purchase of stocks with RV ratings above 1.00.



VectorVest Testimonials

RS (Relative Safety): RS is an indicator of risk. CVBK has an RS rating of 0.69, which is poor on a scale of 0.00 to 2.00. RS is computed from an analysis of the consistency and predictability of a company 's financial performance, debt to equity ratio, sales volume, business longevity, price volatility and other factors. A stock with an RS rating greater than 1.00 is safer and more predictable than the average stock in the VectorVest database. VectorVest favors the purchase of stocks of companies with consistent, predictable financial performance.

RT (Relative Timing): RT is a fast, smart, accurate indicator of a stock 's price trend. CVBK has a Relative Timing rating of 1.17, which is good on a scale of 0.00 to 2.00. RT is computed from an analysis of the direction, magnitude, and dynamics of a stock 's price movements over one day, one week, one quarter and one year time periods. Once a stock 's price has established a strong trend, it is expected to continue in that trend for the short-term. If a trend dissipates, RT will gravitate toward 1.00. RT will explode from bottoms, dive from tops, and reflect changes in price momentum. VectorVest favors the purchase of stocks with RT ratings above 1.00.

VST (VST-Vector): VST is the master indicator for ranking every stock in the VectorVest database. CVBK has a VST rating of 1.00, which is fair on a scale of 0.00 to 2.00. VST is computed from the square root of a weighted sum of the squares of RV, RS, and RT. Stocks with the highest VST ratings have the best combinations of Value, Safety and Timing. These are the stocks to own for above average, long-term capital appreciation. VectorVest advocates the purchase of safe, undervalued stocks rising in price.

Recommendation (REC): VectorVest gives a Buy, Sell, Hold recommendation on every stock, every day. CVBK has a Hold recommendation. REC reflects the cumulative effect of all the VectorVest parameters working together. These parameters are designed to help investors buy safe, undervalued stocks rising in price. They also help investors avoid or sell risky, overvalued stocks falling in price. VectorVest recommends that investors buy high VST-Vector, Buy-rated stocks in rising markets.

OR

Stop (Stop-Price): Stop is an indicator of when to sell a long position or cover a short position. CVBK has a Stop of $0.73 per share. This is $0.11 below below CVBK 's current closing Price. A stock 's Stop is computed from a 13 week moving average of its closing prices, and is fine-tuned according to the stock 's fundamentals. High RV, high RS stocks have lower Stops, and low RV, low RS stocks have higher Stops. In the VectorVest system, a stock gets a 'B ' or 'H ' recommendation if its Price is above its Stop and an 'S ' recommendation if its Price is below its Stop.

GRT (Earnings Growth Rate): GRT reflects a company 's one to three year forecasted earnings growth rate in percent per year. CVBK has a forecasted Earnings Growth Rate of 14.00%, which VectorVest considers to be good. GRT is computed from historical, current and forecasted earnings data. It is updated each week for every stock in the VectorVest database. GRT often foretells a stock 's future price trend. If a stock 's GRT trend is upward, the stock 's price will likely rise. If GRT is trending downward, the stock 's Price will probably fall. VectorVest favors the purchase of stocks whose GRT is rising and is greater than the sum of current inflation and interest rates, as shown weekly in our investment climate report.

EPS (Earnings per Share): EPS stands for leading 12 months Earnings Per Share. CVBK has a forecasted EPS of $0.07 per share. VectorVest determines this forecast from a combination of recent earnings performance and traditional fiscal and/or calendar year earnings forecasts.

P/E (Price to Earnings Ratio): P/E is a popular measure of stock valuation which shows the dollars required to buy one dollar of earnings. CVBK has a P/E of 12.00. This ratio may be deemed to be high or low depending upon your frame of reference. The average P/E of all the stocks in the VectorVest database is 38.97. P/E is computed daily using the formula: P/E = Price/EPS.

EY (Earnings Yield): EY reflects earnings per share as a percent of Price. EY is related to P/E via the formula, EY = 100 / (P/E), and may be used in place of P/E as a measure of valuation. EY has the advantages that it is always determinate and can reflect negative earnings. CVBK has an EY of 8.33 percent. This is above the current average of 2.55% for all the stocks in the VectorVest database. EY equals 100 x (EPS/Price).

GPE (Growth to P/E Ratio): GPE is another popular measure of stock valuation. It compares earnings growth rate to P/E ratio. CVBK has a GPE rating of 1.17. High growth stocks are believed to be able to justify high P/E ratios. A stock is commonly considered to be undervalued when GPE is greater than 1.00 and overvalued when GPE is below 1.00. Unfortunately, this rule of thumb does not take into account the effect of interest rates on P/E ratios. The operative GPE ratio of 1.00 is valid when and only when interest rates equal 10%. With long-term interest rates currently at 2.63%, the operative GPE ratio is 0.07. Therefore, CVBK may be considered to be undervalued.

Dividend Information

DIV (Dividend): VectorVest reports annual, regular, cash dividends as indicated by the most recent payments. Special distributions, one-time payments, stock dividends, etc., are not generally included in DIV. CVBK does not pay a dividend.

DY (Dividend Yield): DY reflects dividend per share as a percent of Price. CVBK does not pay a dividend, so it does not have a Dividend Yield rating . DY equals 100 x (DIV/Price). It is useful to compare DY with EY. If DY is not significantly lower than EY, the dividend payment may be in jeopardy.

DS (Dividend Safety): DS is an indicator of the assurance that regular cash dividends will be declared and paid at current or at higher rates for the foreseeable future. CVBK does not pay a dividend, so it does not have a Dividend Safety rating . Stocks with DS values above 75 typically have RS values well above 1.00 and EY levels that are much higher than DY.

DG (Dividend Growth Rate): Dividend Growth is a subtle yet important indicator of a company 's financial performance. It also provides some insight into the board 's outlook on the company 's ability to increase earnings. CVBK does not pay a dividend, so it does not have a Dividend Growth rating .

YSG (YSG-Vector): YSG is an indicator which combines DIV, DY and DG into a single value, and allows direct comparison of all dividend-paying stocks in the database. CVBK does not pay a dividend, so it does not have a YSG rating which is . Stocks with the highest YSG values have the best combinations of Dividend Yield, Safety and Growth. These are the stocks to buy for below current income and long-term growth.

Price-Volume Data

Price: CVBK closed on Wednesday, February 13, 2013 at $0.84 per share.

Open: CVBK opened trading at a price of $0.84 per share on Wednesday, February 13, 2013.

High: CVBK traded at a High price of $0.84 per share on Wednesday, February 13, 2013.

Low: CVBK traded at a Low price of $0.84 per share on Wednesday, February 13, 2013.

Close: CVBK closed on Wednesday, February 13, 2013 at $0.84 per share. (Close is also called Price in the VectorVest system)

Range: Range reflects the difference between the High and Low prices for the day. CVBK traded with a range of $0.00 per share on Wednesday, February 13, 2013.

$ Change: CVBK unchanged from the prior day 's closing Price.

%PRC: CVBK 's Price changed 0.00% from the prior day 's closing price.

Volume: CVBK traded 200 shares on Wednesday, February 13, 2013.

AvgVol: AvgVol is the 50 day moving average of daily volume as computed by VectorVest. CVBK has an AvgVol of 2,680 shares traded per day.

%Vol: %Vol reflects the percent change in today 's trading volume as compared to the AvgVol. %Vol equals ((Volume - AvgVol) / AvgVol ) * 100. CVBK had a %Vol of -92.54% on Wednesday, February 13, 2013

CI (Comfort Index): CI is an indicator which reflects a stock 's ability to resist severe and/or lengthy price declines. CVBK has a CI rating of 0.53, which is poor on a scale of 0.00 to 2.00. CI is quite different from RS in that it is based solely upon a stock 's long-term price history. VectorVest advocates the purchase of high CI stocks.

Sales / Market Capitalization Information

Sales: CVBK has annual sales of 15,000,000

Sales Growth: Sales Growth is the Sales Growth Rate in percent over the last 12 months. CVBK has a Sales Growth of -19.00% per year. This is very poor. Sales Growth is updated each week for every stock. It is often useful to compare Sales Growth to Earnings Growth to gain an insight into a company 's operations.

Sales Per Share (SPS): CVBK has annual sales of $5.63 per share. SPS can be used as a measure of valuation when comparing stocks within an Industry Group.

Price to Sales Ratio (P/S): CVBK has a P/S of 0.15. This ratio is also used as a measure of valuation. Here, too, it is useful when comparing stocks within an Industry Group.

Shares: CVBK has 2,000,000 shares of stock outstanding.

Market Capitalization: CVBK has a Market Capitalization of 2,000,000. Market Capitalization is calculated by multiplying price times shares outstanding.

Business Sector: CVBK has been assigned to the Bank Business Sector. VectorVest classifies stocks into over 200 Industry Groups and 40 Business Sectors.

Industry Group: CVBK has been assigned to the Bank (Southeast) Industry Group. VectorVest classifies stocks into over 200 Industry Groups and 40 Business Sectors.

For another stock analysis, please click here.

Please do not reply to this email. For answers to your questions, please call 1-888-658-7638, or email us at support@vectorvest.com .

Copyright 2010 by VectorVest, Inc. All Rights Reserved.
20472 Chartwell Center Drive, Cornelius NC 28031
For additional information, call 1-888-658-7638, e-mail to support@vectorvest.com ,
or visit our internet site at http://www.vectorvest.com

For international phone numbers please click here.

DISCLAIMER: VectorVest is licensed by VectorVest, Inc., and is protected by United States copyright laws and international treaty provisions. The information contained herein is for your exclusive, personal use only. You may print a single copy of any stock analysis for your exclusive use, but it is not to be reproduced for distribution without the expressed written consent of VectorVest, Inc. You should be aware of the risks involved in stock investing, and you use the material contained herein at your own risk. This material is believed to be reliable, but neither VectorVest, Inc., nor any of its suppliers guarantee its accuracy or validity, nor are they responsible for any errors or omissions which may have occurred. The analysis, ratings, and/or recommendations made by VectorVest, and/or any of its suppliers do not provide, imply, or otherwise constitute a guarantee of performance.

VectorVest is comprised of reports embodying a unique system of stock analysis. All contents and recommendations are based on data and sources believed to be reliable, but accuracy and completeness cannot be guaranteed. Users should be aware of the risks involved in stock investments. It should not be assumed that future results will be profitable or will equal past performance, real, indicated or implied. VectorVest and/or its principals may purchase or sell any of the securities cited herein. VectorVest and the logostyle, geometric design are, individually and collectively, service marks owned by VectorVest, Inc. VectorVest is published daily by VectorVest, Inc. 20472 Chartwell Center Drive Cornelius, NC 28031 704-895-4095

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cascades Eyes New Quebec Govt for Growth Partnerships

Updated Category News Views 3

Quebec's New Ministers: A Fresh Start or the Same Old? So the suits in Quebec have shuffled about and Cascades Inc. (TSX: CAS)—a heavyweight in sustainable papermaking—is polishing their best handshake. They're rolling out the welcome mat for the new ministers in the Government of Quebec. As someone who've seen their fair share of this song and dance, the real...

Continue Reading
Sivers Semiconductors Shakes Up Auditors and Incentives

Updated Category News Views 0

Rethinking the Auditing Game Well, what do you know? Sivers Semiconductors just gave the boot to Deloitte AB. Looks like they're rolling out the welcome mat for Ernst & Young AB to scrutinize their books instead. The move, coming hot from the Extraordinary General Meeting, shows they're not messing around with their financial oversight. Maybe it's a bid for fresh...

Continue Reading
Procede Software Acquires RIMSS: Dealer Tech Shift?

Updated Category News Views 3

Procede's Big Play Seems like Procede Software is tossing the dice with its latest move. The software scene for dealership management is as cutthroat as a New York deli lineup, and now we've got Procede moving to scoop up RIMSS. This isn't just a back-office shuffle; it's a world-rocking maneuver that brings decades of dealer technology know-how into one basket. What's...

Continue Reading
Green Builder Media's Fresh Focus on Net Zero Homes

Updated Category News Views 2

There's a fresh breeze blowing through the building industry, and it's got "net zero" written all over it. Green Builder Media is rolling out a pile of new resources aimed at wrangling this beast of a trend. The focus? High-performance, all-electric homes. And they're not just whispering about it—they've got hard data and practical guidance to back up their claims. Net...

Continue Reading
Mercuryo's Swaps: A New Era in Crypto Trading Flexibility

Updated Category News Views 8

Mercuryo's Bold Leap into Crypto Flexibility Mercuryo thinks they've got this crypto game figured out, tossing a curveball into the market with Swaps. It's like they're saying, "Here, make your moves without the usual headaches." Launched on October 22, 2026, this product lets folks trade between 38 digital tokens and struts out 700 possible trading pairs—and that's...

Continue Reading
Labcorp, FDA Collaborate to Tackle Drug Abuse Risks

Updated Category News Views 3

Rethinking How We Evaluate Drug Abuse Potential Sometimes, the finance world gets a peek into something that ain't just about the numbers on a screen, something with real stakes beyond the bulls and bears. Labcorp's just thrown its hat in with the FDA and Charles River Laboratories in a collaboration that goes beyond just lining pockets. They're setting up to dissect how...

Continue Reading
Granite Gives Pink Raises $583K for Cancer Research

Updated Category News Views 1

Not Just About Numbers: Employee-Led Push for Health If you've ever doubted the power of collective purpose, take a look at Granite Telecommunications' recent endeavor. This hard-hitting telecom giant, with its robust footprint across North America's communication and tech sectors, isn't resting on its laurels when it comes to social responsibility. Their 'Granite Gives...

Continue Reading
CobbleStone & Chu Chua Tech: A Transformative Alliance

Updated Category News Views 2

Breaking Down the CobbleStone and Chu Chua Collaboration We’re in a tough, interconnected world where tech innovation is racing against the clock. So, when CobbleStone Software raises its hand to join forces with Chu Chua Technology Services LLP, it’s like a shot of adrenaline for anyone invested in North America’s tech wave. Let’s pause and dive right in because...

Continue Reading
QFIN Investors Eye Class Action Amid Regulatory Struggles

Updated Category News Views 2

QFIN Shareholders Unite Amid Regulatory Storm It's not every day you see a stock nosedive by nearly 19% overnight. But when you're investing in a company like Qfin Holdings, you get ready for a wild ride, especially when regulatory changes from China come into play. That's exactly what's happening right now as investors rally around a class action lawsuit against Qfin....

Continue Reading
Bambu Lab Shakes Up 3D Printing with Massive Discounts

Updated Category News Views 5

Price Cuts Bring 3D Printing Mainstream Here's the deal—3D printing used to be the domain of the tech-savvy elite, akin to those early computer geeks holed up in garages. But now? Bambu Lab is throwing open those doors with its Black Friday and Cyber Monday specials, slashing prices like a man on a mission. They're bringing an entire technological leap into our hands,...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSyent Reports Impressive Financial Growth in Recent Quarter

Updated Category News Views 143

BioSyent's Financial Performance Overview BioSyent Inc. has recently announced its financial outcomes for the second quarter (Q2) and the first half (H1) of the year, showing promising growth across all sectors. The company, known for its innovative pharmaceutical products, reported notable increases in sales and profit margins. This positive trend reflects its strong...

Continue Reading
MediCapture Unveils Innovative aiScope™ for Veterinary Applications

Updated Category News Views 108

MediCapture Introduces aiScope™ for Veterinary Training Revolutionizing Medical AI CHEROKEE, Texas — MediCapture Inc., recognized for its prowess in medical imaging technology, has announced the exciting launch of aiScope™. This innovative software operates Vision AI models in real-time, directly on selected MediCapture devices, providing tremendous opportunities in...

Continue Reading
EquipmentShare Faces Class Action Over $77M Misconduct

Updated Category News Views 9

Unpacking the EquipmentShare Fiasco Woah, can't say there aren't fireworks going off at EquipmentShare (NASDAQ:EQPT) these days. Lawsuits piling up like pancakes at a Sunday brunch. And guess what? EquipmentShare's stock took a nosedive, shaking retail investors down to their core. This ain't just any bump in the road—it's messy, sticky, and if you're holding $EQPT,...

Continue Reading
BioCryst Pharmaceuticals Welcomes Babar Ghias as CFO

Updated Category News Views 403

Exciting Leadership Change at BioCryst Pharmaceuticals Today, BioCryst Pharmaceuticals, Inc. has announced a significant addition to its leadership team with the appointment of Babar Ghias as Chief Financial Officer (CFO) and head of corporate development. Mr. Ghias will bring to the role a wealth of experience aimed at driving financial strategy and growth within the...

Continue Reading
MMA Digital Corp.: U.S. Banking Infrastructure Playbook

Updated Category Economy Views 30

Getting banking infrastructure right in the United States is genuinely hard. Not hard in a "read more documentation" way. Hard in a "you won't know what you missed until it bites you six months in" way. The U.S. financial system is layered, fragmented, and built on decades of overlapping regulation. For any company trying to move fast, whether entering the market fresh or...

Continue Reading